Clinical Trial Update: Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating moderate hypothermia for neonatal hypoxic-ischemic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Asphyxia
• Neonatal Hypoxic Ischemic Encephalopathy

Snippet

Sponsor: Medical University of South Carolina | Conditions: Neonatal Asphyxial Encephalopathy, Hypoxic Ischemic Encephalopathy | Phase 2 | Status: COMPLETED